ChromaDex Corp CDXC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
-
ChromaDex Appoints Ozan Pamir as Chief Financial Officer
-
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
-
ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions
-
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
-
ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
-
ChromaDex Corporation Reports Second Quarter 2024 Financial Results
-
ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference
Trading Information
- Previous Close Price
- $3.47
- Day Range
- $3.38–3.54
- 52-Week Range
- $1.25–4.65
- Bid/Ask
- $3.36 / $3.40
- Market Cap
- $256.65 Mil
- Volume/Avg
- 167,904 / 280,680
Key Statistics
- Price/Earnings (Normalized)
- 90.21
- Price/Sales
- 2.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Stock Style Box
- Small Core
- Total Number of Employees
- 106
- Website
- https://www.chromadex.com
Comparables
Valuation
|
Metric
|
CDXC
|
002702
|
300765
|
|---|---|---|---|
Price/Earnings (Normalized) | 90.21 | — | 94.24 |
Price/Book Value | 8.30 | 1.89 | 11.11 |
Price/Sales | 2.97 | 1.22 | 19.65 |
Price/Cash Flow | 52.01 | 27.72 | 82.20 |
Price/Earnings
CDXC
002702
300765
Financial Strength
|
Metric
|
CDXC
|
002702
|
300765
|
|---|---|---|---|
Quick Ratio | 1.99 | 0.46 | 2.33 |
Current Ratio | 2.76 | 1.52 | 2.78 |
Interest Coverage | — | 0.59 | 243.51 |
Quick Ratio
CDXC
002702
300765
Profitability
|
Metric
|
CDXC
|
002702
|
300765
|
|---|---|---|---|
Return on Assets (Normalized) | 5.51% | −1.40% | 8.65% |
Return on Equity (Normalized) | 10.42% | −2.69% | 10.59% |
Return on Invested Capital (Normalized) | 6.32% | −1.50% | 8.77% |
Return on Assets
CDXC
002702
300765
Packaged Foods Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Nestle SA ADR
NSRGY
| Ggtwrgbj | Rcb | $252.7 Bil | |||
| Danone SA ADR
DANOY
| Jpyjbmz | Jnbnw | $45.5 Bil | |||
| The Kraft Heinz Co
KHC
| Xscsfgpm | Cqcttg | $41.8 Bil | |||
| General Mills Inc
GIS
| Jjykwpgz | Zydjvzd | $40.9 Bil | |||
| Kellanova Co
K
| Lnxgdlybg | Ztryj | $27.8 Bil | |||
| McCormick & Co Inc Registered Shs Non Vtg
MKC
| Sbjvqgvw | Ghqs | $21.7 Bil | |||
| Hormel Foods Corp
HRL
| Vzjpxrvsz | Kjtyb | $17.2 Bil | |||
| Campbell Soup Co
CPB
| Bbfnrxjzg | Qbtq | $14.1 Bil | |||
| Conagra Brands Inc
CAG
| Fwbyrxfz | Jtph | $14.1 Bil | |||
| JM Smucker Co
SJM
| Jlzm | Rtrw | $12.5 Bil |
United States